Who said it did not trust the data of novel coronavirus vaccine, and urgently authorized national medicine vaccine. Why?

On May 7, 2021, China’s national medicine vaccine has obtained urgent authorization from who

.

Only two days ago, Reuters reported that social experts expressed great distrust in the data of China’s national medicine vaccine

.

So why do the WHO experts have this statement? Who is evaluating whether to approve emergency authorization for two vaccines made in China

.

One is Sinopharm Beijing biological vaccine, the other is Kexing vaccine

.

Whether its Chinese medicine vaccine is approved or not is expected to be released before the end of this week

.

The report said that the results of phase III clinical trials of the Chinese medicine vaccine show that the protective effect of the Chinese medicine vaccine on people aged 18 to 59 is 78.1%

.

The effectiveness of preventive hospitalization was 78.7%, and the safety evaluation was moderately credible

.

But for people over 60 years old, severe patients, patients with complications and so on

.

The report shows that due to the obvious lack of clinical data, the evaluation of protection effectiveness is low credibility, while the safety is very low credibility

.

Chinese medicine vaccine has been authorized in 45 countries or regions

.

For adults aged 18 and over, 65 million doses have been vaccinated through emergency programs

.

We are all very concerned about who’s emergency authorization of Chinese medicine vaccine

.

What kind of decision mechanism is this? For the vaccine industry, it is the World Health Organization (who)

.

If an emergency use license is given to any vaccine, it is equivalent to adding this license to the list, which is very good news for these vaccine companies

.

It is also an endorsement of their whole vaccine product to a certain extent

.

Who actually has a special technical advisory group, the expert group of technical consultants, to decide whether to include the vaccine in such an emergency list

.

So this expert group has only six members in total, so it looks like a process of the final decision of a small team

.

Before this small team makes a decision, it will have a relatively independent one, which is called advisory group all experts of realization

.

It is a group of strategic consultants and experts on immunization

.

Such a team, first of all, makes a relatively independent evaluation of the vaccine and then gives their suggestions

.

Their independent evaluation relatively mentions that part of the data is that their confidence and credibility are very low

.

This word will be slightly different in Chinese, English is called verylowconfidence

.

I have very low confidence in the data presented by Sinopharm

.

Of course, they have these words to express the very objective attitude of experts

.

As a public health expert, they don’t want to say that I don’t want to trust you because it’s a very active way of expression

.

It’s a relatively objective expression to say that your data confidence is very low and your trust is very low

.

We should see that the World Health Organization has made this decision based on several considerations

.

One is the data of the protection rate of Sinopharm

.

For people aged 18, 28 and under 59, the basic protection rate is that the protection rate is mainly for an inpatient, and the protection rate is about 71%

.

In fact, there is another data, that is, the data of all age groups, that is, a small number of people over the age of six, are also included

.

If you think about it, that’s close to 79%

.

Of course, the WHO technical team is the first data they consider

.

In addition, they also see that there are still some favorable conditions for the vaccine itself

.

One is that it is relatively convenient for storage and transportation

.

A simple refrigerator for Chinese medicine vaccines is OK ° To 8 ° In between

.

Therefore, this matter greatly facilitates many countries with poor resource conditions

.

What the world health organization mainly considers is that many countries still want to get the vaccine

.

Anyway, the international community now feels that the vaccine seems to be a universally recognized and epidemic prevention measure

.

Although there will be different efficiency, different products and different views, generally speaking, vaccine is an important means of public epidemic prevention

.

So many countries want to get the vaccine as soon as possible, regardless of their own strength

.

So the World Health Organization also sees this, so it thinks that one more choice of vaccine will be good news for many low GDP countries and developing countries

.

In addition, some new designs have been added to the packaging of this product

.

That is to add a monitoring method to this medicine bottle

.

It can let people know whether the drug has deteriorated or not

.

For example, if the drug is exposed to high temperature, sometimes the truck overheats during transportation, or the sample is exposed to the sun for one or two hours, the ingredients in it may be inactivated

.

So one indicator will change color

.

If the vaccine bottle is complete or exposed to high temperature, they will have color display

.

The person who injected the vaccine is the person who injected the vaccine

.

Before registration, they can judge whether the bottle has problems and can’t be used

.

It’s an extra convenience

.

Therefore, this is also a factor considered by the World Health Organization

.

Then they even sent team members to China to assess the production facilities of Sinopharm’s vaccine

.

So in general, they gave an approval for such an emergency use license for these reasons, so that’s the reason for the vaccine authorization passed on Friday..

.